Clinical Trial: A Study Involving Participants With Atrial Fibrillation (AF) to Assess an Approach Where They Take Their Anticoagulation in Response to AF Episodes: This Approach is Guided by Heart Rhythm Monitoring and Automated Smartphone Alerts

U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06922695) titled 'A Study Involving Participants With Atrial Fibrillation (AF) to Assess an Approach Where They Take Their Anticoagulation in Response to AF Episodes: This Approach is Guided by Heart Rhythm Monitoring and Automated Smartphone Alerts' on April 03.

Brief Summary: Atrial Fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting 1-2 million people in the UK. AF is characterised by uncoordinated electrical activation and ineffective contraction of the upper cardiac chambers. AF can occur in temporary episodes, as in paroxysmal AF, or can be sustained continuously beyond 7 days' duration, as in persistent AF.

The most ...